Profilo
Jason Mark Brooks currently works at NeuTec Pharma Ltd., as Director from 2019, Novartis Pharmaceuticals UK Ltd., as Director from 2019, Sandoz Ltd., as Director from 2019, Vivacta Ltd., as Director from 2019, Novartis UK Ltd., as Director from 2019, Novartis Grimsby Ltd., as Director from 2019, Ziarco Pharma Ltd., as Director from 2019, Novartis Europharm Ltd., as Director from 2019, Oriel Therapeutics Ltd., as Director from 2019, and Gyroscope Therapeutics Holdings Plc, as Director from 2022.
Posizioni attive di Jason Mark Brooks
| Società | Posizione | Inizio |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Direttore/Membro del Consiglio | 17/02/2022 |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Direttore/Membro del Consiglio | 09/05/2019 |
Novartis Grimsby Ltd.
Novartis Grimsby Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore/Membro del Consiglio | 09/05/2019 |
Sandoz Ltd.
Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets medicines | Direttore/Membro del Consiglio | 01/05/2019 |
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets general medicines and pharmaceutical products | Direttore/Membro del Consiglio | 09/05/2019 |
Novartis Europharm Ltd.
Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Direttore/Membro del Consiglio | 01/05/2019 |
NeuTec Pharma Ltd.
NeuTec Pharma Ltd. BiotechnologyHealth Technology Develops biopharmaceutical products | Direttore/Membro del Consiglio | 01/05/2019 |
Ziarco Pharma Ltd.
Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases | Direttore/Membro del Consiglio | 01/05/2019 |
Oriel Therapeutics Ltd.
Oriel Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore/Membro del Consiglio | 01/05/2019 |
Precedenti posizioni note di Jason Mark Brooks
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
NeuTec Pharma Ltd.
NeuTec Pharma Ltd. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Health Technology |
Sandoz Ltd.
Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets medicines | Health Technology |
Vivacta Ltd.
Vivacta Ltd. Medical SpecialtiesHealth Technology Develops piezofilm-based chemical detection technology | Health Technology |
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets general medicines and pharmaceutical products | Health Technology |
Novartis Grimsby Ltd.
Novartis Grimsby Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ziarco Pharma Ltd.
Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases | Health Technology |
Novartis Europharm Ltd.
Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
Oriel Therapeutics Ltd.
Oriel Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Gyroscope Therapeutics Holdings Plc
Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
















